Yingde Greatchem Chemicals (300804.SZ) subsidiary construction project some units enter trial production stage.
Yingde Greatchem Chemicals (300804.SZ) announced that on September 29, 2026, its wholly-owned subsidiary Hubei Shengkang Chemical Co., Ltd. ("Shengkang Chemical") received the "Notice of Trial Production for Hazardous Chemicals Construction Project" [Yigao Hazardous Chemicals Project Notice No. [2026] 14] issued by the Emergency Management Bureau of the Yichang High-tech Zone Management Committee.
Yingde Greatchem Chemicals (300804.SZ) announced that on September 29, 2026, its wholly-owned subsidiary Hubei Shengkang Chemical Co., Ltd. ("Shengkang Chemical") received the "Notice of Trial Production for Hazardous Chemicals Construction Project" [Yi Gao Wei Hua Project Notice No. (2026) 14] issued by the Emergency Management Bureau of the Yichang High-tech Zone Management Committee. The Emergency Management Bureau of the Yichang High-tech Zone Management Committee approved the trial production plan for Shengkang Chemical's 2-nitro-3-methylbenzoic acid production facility and part of the product production facilities of the company's fundraising investment project, the "Annual Production of 5,500 Tons of Specialty Chemicals Construction Project." The trial production period is from October 9, 2026 to October 8, 2027. Subsequently, Shengkang Chemical will strictly follow legal and regulatory requirements and the product production process flow to arrange trial production in an orderly manner, and gradually promote the trial production facilities to reach full capacity and meet standards.
2-nitro-3-methylbenzoic acid is an important organic synthesis intermediate, primarily used in the synthesis of N,3-dimethyl-5-chloro-2-aminobenzamide (K-amine), and ultimately used in the production of the highly effective insecticide chlorantraniliprole. The gradual release of production capacity for 2-nitro-3-methylbenzoic acid will help the company expand production scale, enrich its product portfolio, and broaden its customer base, and will have a positive impact on the company's future operating performance.
Related Articles

Hunan Yuneng New Energy Battery Material (301358.SZ) plans to launch a 2026 restricted stock incentive plan.

GENSCRIPT BIO(01548): CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026

Zhangzhou Pientzehuang Pharmaceutical (600436.SH) Chairman Lin Zhihui leaves office due to work adjustment.
Hunan Yuneng New Energy Battery Material (301358.SZ) plans to launch a 2026 restricted stock incentive plan.

GENSCRIPT BIO(01548): CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026

Zhangzhou Pientzehuang Pharmaceutical (600436.SH) Chairman Lin Zhihui leaves office due to work adjustment.






